Century Therapeutics, Inc. - Common Stock, $0.0001 par value per share (IPSC)

60 filings reported holding IPSC - Century Therapeutics, Inc. - Common Stock, $0.0001 par value per share as of Q3 2021.
Century Therapeutics, Inc. - Common Stock, $0.0001 par value per share (IPSC) has 47 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 19,798,633 shares of 86,307,537 outstanding shares and own 22.94% of the company stock.
Largest 10 shareholders include FMR LLC (8,160,524 shares), Casdin Capital, LLC (3,206,380 shares), FEDERATED HERMES, INC. (1,164,094 shares), RA CAPITAL MANAGEMENT, L.P. (914,094 shares), Avidity Partners Management LP (739,269 shares), BlackRock Inc. (648,656 shares), Logos Global Management LP (639,095 shares), HHLR ADVISORS, LTD. (614,095 shares), Octagon Capital Advisors LP (602,623 shares), and Marshall Wace North America L.P. (571,053 shares).
This table shows the top 47 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.